Myristic acid selectively augments β‐tubulin levels in C2C12 myotubes via diacylglycerol kinase δ

Myristic acid selectively augments β‐tubulin levels in C2C12 myotubes via diacylglycerol kinase δ

Effective amelioration of type II diabetes requires therapies that increase both glucose uptake activity per cell and skeletal muscle mass. Myristic acid (14:0) increases diacylglycerol kinase (DGK) δ protein levels and enhances glucose uptake in myotubes in a DGKδ‐dependent manner. However, it is s...

Full description

Bibliographic Details
Main Authors: Hiromichi Sakai, Ken‐ichi Matsumoto, Takeshi Urano, Fumio Sakane
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:FEBS Open Bio
Subjects:
diacylglycerol kinase
myotube
myristic acid
type II diabetes
β‐tubulin
Online Access:https://doi.org/10.1002/2211-5463.13466

Similar Items

Similar Items